[Usefulness of the administration of retinol palmitate to patients operated on for non-small-cell lung carcinoma in first 'A' stage].
Soresi
E
E
Pastorino
U
U
Chiesa
G
G
Clerici
M
M
Invernizzi
G
G
Harari
S
S
Brando
B
B
D000328:Adult; D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology / Q000517:prevention & control* / Q000601:surgery; D003131:Combined Modality Therapy; D004224:Diterpenes; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000517:prevention & control* / Q000601:surgery; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D009367:Neoplasm Staging; D000084562:Retinyl Esters; D014801:Vitamin A / Q000031:analogs & derivatives* / Q000627:therapeutic use
D016588:Anticarcinogenic Agents; D004224:Diterpenes; D000084562:Retinyl Esters; D014801:Vitamin A; C014794:retinol palmitate
Utilità della somministrazione di retinolo palmitato ai pazienti operati di carcinoma polmonare non microcitoma in 1st stadio 'A'.